Comparative analysis of molecular 3D metrics in fragment space and beyond

IF 7.5 2区 医学 Q1 PHARMACOLOGY & PHARMACY
Tom Dekker, Maikel Wijtmans, Iwan J.P. de Esch
{"title":"Comparative analysis of molecular 3D metrics in fragment space and beyond","authors":"Tom Dekker,&nbsp;Maikel Wijtmans,&nbsp;Iwan J.P. de Esch","doi":"10.1016/j.drudis.2025.104443","DOIUrl":null,"url":null,"abstract":"<div><div>Within the fragment-based drug discovery (FBDD) community, there is growing interest in developing non-planar, 3D screening fragments to complement the predominantly 2D structures that currently populate fragment libraries. Molecular three-dimensionality is typically evaluated using metrics such as the fraction of sp<sup>3</sup>-hybridized carbon atoms (F<sub>C</sub>sp<sup>3</sup>), plane of best fit (PBF) and/or principal moment of inertia (PMI). In this study, we review these 3D metrics and perform systematic cheminformatic analyses. Furthermore, we explore the use of alternative metrics that consider atom hybridization for the assessment of molecular shape. Although our analysis is grounded in a fragment-based context, the insights gained are broadly applicable across the drug discovery phases.</div></div>","PeriodicalId":301,"journal":{"name":"Drug Discovery Today","volume":"30 9","pages":"Article 104443"},"PeriodicalIF":7.5000,"publicationDate":"2025-07-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Drug Discovery Today","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1359644625001564","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0

Abstract

Within the fragment-based drug discovery (FBDD) community, there is growing interest in developing non-planar, 3D screening fragments to complement the predominantly 2D structures that currently populate fragment libraries. Molecular three-dimensionality is typically evaluated using metrics such as the fraction of sp3-hybridized carbon atoms (FCsp3), plane of best fit (PBF) and/or principal moment of inertia (PMI). In this study, we review these 3D metrics and perform systematic cheminformatic analyses. Furthermore, we explore the use of alternative metrics that consider atom hybridization for the assessment of molecular shape. Although our analysis is grounded in a fragment-based context, the insights gained are broadly applicable across the drug discovery phases.
分子三维度量在片段空间和其他空间的比较分析。
在基于片段的药物发现(FBDD)社区中,人们对开发非平面的3D筛选片段越来越感兴趣,以补充目前填充片段库的主要2D结构。通常使用sp3杂化碳原子分数(FCsp3)、最佳拟合面(PBF)和/或主转动惯量(PMI)等指标来评估分子的三维性。在这项研究中,我们回顾了这些三维指标,并进行了系统的化学信息分析。此外,我们探索使用替代指标,考虑原子杂交分子形状的评估。虽然我们的分析是基于片段的背景,但所获得的见解广泛适用于药物发现阶段。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Drug Discovery Today
Drug Discovery Today 医学-药学
CiteScore
14.80
自引率
2.70%
发文量
293
审稿时长
6 months
期刊介绍: Drug Discovery Today delivers informed and highly current reviews for the discovery community. The magazine addresses not only the rapid scientific developments in drug discovery associated technologies but also the management, commercial and regulatory issues that increasingly play a part in how R&D is planned, structured and executed. Features include comment by international experts, news and analysis of important developments, reviews of key scientific and strategic issues, overviews of recent progress in specific therapeutic areas and conference reports.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信